# US 2016/0257686 A1 · Purinone Derivatives as Tyrosine Kinase Inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0257686 A1
- Document ID: US20160257686A1
- Status: Published application
- Kind: A1
- Application number: 14/997,248
- Filed: 2016-01-15
- Published: 2016-09-08
- Earliest claimed: 2012-11-20
- Assignees: Principia Biopharma Inc.
- Applicants: Principia Biopharma Inc.
- Inventors: Timothy D. OWENS
- Web page: https://patentgrep.com/patent/US20160257686A1

## CPC

- C07D 473/34: attached in position 6, e.g. adenine
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/0043: {Nose}
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 9/0078: {for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions}
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/2018: {Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates}
- A61K 9/4858: {Organic compounds}
- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present disclosure provides compounds and pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BLK, BMX, EGFR, HER2, HER4, ITK, TEC, BTK, and TXK and are therefore useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as autoimmune diseases, cancer and inflammatory diseases. Also provided are pharmaceutical compositions containing such compounds and pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.

## Claims

### Claim 1

A compound of Formula (I):
wherein:
L is O, CO, CH2, S, SO, SO2, NR, NRCO, CONR, or NRCONR′, where (each R and R′ is independently hydrogen or alkyl);
Ar is aryl, heteroaryl, cycloalkyl or heterocyclyl;
R1 is hydrogen, alkyl, cyclopropyl, hydroxy, alkoxy, cyano, halo, haloalkyl or haloalkoxy;
R2 is hydrogen, alkyl, alkynyl, cyclopropyl, alkylamino, dialkylamino, alkylthio, alkylsulfonyl, carboxy, alkoxycarbonyl, alkylaminosulfonyl, dialkylaminosulfonyl, —CONH2, alkylaminocarbonyl, dialkylaminocarbonyl, 3-, 4-, or 5-membered heterocylyl, hydroxy, alkoxy, cyano, halo, haloalkyl or haloalkoxy;
R3, R4, and R5 are independently hydrogen, alkyl, hydroxy, alkoxy, halo, haloalkyl, haloalkoxy, carboxy, alkoxycarbonyl, cyano, —CONH2, amino, or monosubstituted or disubstituted amino;
X is alkylene, -alkynylene-NRa—, cycloalkylene, -alkylene-O—, -cycloalkylene-NRa—, (alkylene)-NRa—, -phenylene-NRa— (where each Ra is hydrogen, alkyl or cycloalkyl), or
(where Z is bond or alkylene, and ring A is heterocycloamino optionally substituted with one or two substituents independently selected from alkyl, hydroxy, alkoxy, or fluoro);
Y is —CO— or —SO2—;
Rc is alkyl, haloalkoxy, substituted alkyl, cycloalkyl, 1-(alkyleneRb)-cycloalkan-1-yl (where Rb is amino, alkylamino, dialkylamino, hydroxy, or monocyclic heteroaryl), 1-NRdRecycloalkan-1-yl (where Rd and Re are independently hydrogen, alkyl, or cycloalkyl), or 3 to 6 membered saturated monocyclic heterocyclyl containing one or two heteroatoms selected from N, O, or S and optionally substituted with one or two substituents independently selected from hydroxy, alkoxy, alkyl, fluoro, aminoalkyl, hydroxyalkyl, or alkoxyalkyl;
or a pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

The compound or a pharmaceutically acceptable salt of claim 1 wherein:
L is O and is attached at the 4-position of the phenyl ring with the carbon atom of the phenyl ring attached to purinone nitrogen being position 1; and
R1 and R2 are independently hydrogen, alkyl, halo, haloalkyl, or alkoxy.

### Claim 3 (depends on 2)

The compound or a pharmaceutically acceptable salt of claim 2
wherein R1 is hydrogen or halo; and
R2 is hydrogen.

### Claim 4 (depends on 2)

The compound or a pharmaceutically acceptable salt of claim 2
wherein R1 and R2 are hydrogen.

### Claim 5 (depends on 2)

The compound or a pharmaceutically acceptable salt of claim 2 wherein
is a ring of formula:

### Claim 6 (depends on 2)

The compound or a pharmaceutically acceptable salt of claim 2 wherein
is phenyl.

### Claim 7 (depends on 2)

The compound or a pharmaceutically acceptable salt of claim 2 wherein —X— is -cycloalkylene-NRa—, -(alkynylene)-NRa—, -(alkylene)-NRa—, -phenylene-NRa— (where each Ra is hydrogen, alkyl or cycloalkyl), or
Z is a bond or alkylene;
ring A is heterocycloamino optionally substituted with one or two substituents independently selected from alkyl, hydroxy, alkoxy, or fluoro; and
Y is CO.

### Claim 8 (depends on 2)

The compound or a pharmaceutically acceptable salt of claim 2 wherein —X—Y— is:

### Claim 9 (depends on 2)

The compound or a pharmaceutically acceptable salt of claim 2 wherein —X—Y— is:
where the stereochemistry at *C is R or S.

### Claim 10 (depends on 9)

The compound or a pharmaceutically acceptable salt of claim 9 wherein Rc is cycloalkyl.

### Claim 11 (depends on 9)

The compound or a pharmaceutically acceptable salt of claim 9 wherein Rc is alkyl.

### Claim 12 (depends on 9)

The compound or a pharmaceutically acceptable salt of claim 9 wherein Rc is alkyl substituted with hydroxyl, alkoxy, —NRR′ (where R is hydrogen, alkyl, alkoxyalkyl, heterocyclyl or cycloalkyl and R′ is hydrogen or alkyl), or heterocycicyl which is optionally substituted with one or two groups independently selected from alkyl.

### Claim 13 (depends on 9)

The compound or a pharmaceutically acceptable salt of claim 9 wherein Rc is 3- to 6-membered saturated monocyclic heterocyclyl containing one or two heteroatoms selected from N, O, or S and optionally substituted with one or two substituents selected from hydroxy, alkyl or fluoro.

### Claim 14 (depends on 1)

A pharmaceutical composition comprising a compound or a pharmaceutically acceptable salt of claim 1, and a pharmaceutically acceptable excipient.

### Claim 15 (depends on 1)

A method of treating an autoimmune disease, inflammatory disease or cancer which method comprises administering to the patient in need thereof, a pharmaceutical composition comprising a compound or a pharmaceutically acceptable salt of claim 1 optionally in combination with one or more anticancer or anti-inflammatory agents.

### Claim 16 (depends on 15)

The method of claim 15 wherein the disease is leukemia or lymphoma.

### Claim 17 (depends on 15)

The method of claim 15 wherein the leukemia is chosen from chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), multiple myeloma, mantle cell lymphoma, and B-cell non-Hodgkin lymphoma.

### Claim 18 (depends on 15)

The method of claim 15 wherein the disease is arthritis, lupus, Sjogren's dry eye, non-Sjogren's dry eye, or asthma.

### Claim 19

A compound selected from:
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-3-cyclopropylacrylonitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-3-cyclopropylacrylonitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-3-cyclopropylacrylonitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-3-cyclopropylacrylamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-3-cyclopropylacrylamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-3-cyclopropylacrylonitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-3-cyclopropylacrylonitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-3-cyclopropylacrylonitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-3-cyclopropylacrylonitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-3-cyclopropylacrylamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
3-cyclopropylacrylamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
3-cyclopropyl-N-methylacrylamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4,4-dimethylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4,4-dimethylpent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4,4-dimethylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4,4-dimethylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4,4-dimethylpent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4,4-dimethylpent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4,4-dimethylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4,4-dimethylpent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-cyano-dimethylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4,4-dimethylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4,4-trimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methylpent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-methylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methylpent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methylpent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-methylpent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-4-amino-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-
purin-9(8H)-yl)methyl)pyrrolidine-1-carbonyl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-4-amino-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-
purin-9(8H)-yl)piperidine-1-carbonyl)-4-methylpent-2-enenitrile;
4-amino-2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-4-amino-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-
purin-9(8H)-yl)propan-2-yl)-2-cyano-4-methylpent-2-enamide;
4-amino-N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)cyclohexyl)-2-cyano-4-methylpent-2-enamide;
(RS), (R), or (S)-4-amino-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-
purin-9(8H)-yl)methyl)azetidine-1-carbonyl)-4-methylpent-2-enenitrile;
4-amino-2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methylpent-2-enenitrile;
4-amino-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)azetidine-1-carbonyl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-4-amino-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-
purin-9(8H)-yl)pyrrolidine-1-carbonyl)-4-methylpent-2-enenitrile;
4-amino-N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methylpent-2-enamide;
4-amino-N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)ethyl)-2-cyano-4-methylpent-2-enamide;
4-amino-N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)ethyl)-2-cyano-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-ethoxy-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-ethoxy-4-methylpent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-ethoxy-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-ethoxy-4-methylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-ethoxy-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-ethoxy-4-methylpent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-ethoxy-4-methylpent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-ethoxy-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-ethoxy-4-methylpent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-ethoxy-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-ethoxy-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-ethoxy-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-(dimethylamino)-4-methylpent-2-
enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-(dimethylamino)-4-methylpent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-(dimethylamino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-(dimethylamino)-4-methylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-(dimethylamino)-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(dimethylamino)-4-methylpent-2-
enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(dimethylamino)-4-methylpent-2-
enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-(dimethylamino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-(dimethylamino)-4-methylpent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-(dimethylamino)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(dimethylamino)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(dimethylamino)-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-methyl-4-morpholinopent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methyl-4-morpholinopent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-methyl-4-morpholinopent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-methyl-4-morpholinopent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-methyl-4-morpholinopent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-morpholinopent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-morpholinopent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-methyl-4-morpholinopent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-methyl-4-morpholinopent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methyl-4-morpholinopent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-methyl-4-morpholinopent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4-dimethyl-4-morpholinopent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-methyl-4-(methylamino)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methyl-4-(methylamino)pent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-methyl-4-(methylamino)pent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-methyl-4-(methylamino)pent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-methyl-4-(methylamino)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(methylamino)pent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(methylamino)pent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-methyl-4-(methylamino)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-methyl-4-(methylamino)pent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methyl-4-(methylamino)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-methyl-4-(methylamino)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4-dimethyl-4-(methylamino)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-(ethylamino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-(ethylamino)-4-methylpent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-(ethylamino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-(ethylamino)-4-methylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-(ethylamino)-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(ethylamino)-4-methylpent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(ethylamino)-4-methylpent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-(ethylamino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-(ethylamino)-4-methylpent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-(ethylamino)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(ethylamino)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(ethylamino)-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-methyl-4-(methyl(oxetan-3-
yl)amino)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methyl-4-(methyl(oxetan-3-yl)amino)pent-2-
enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-methyl-4-(methyl(oxetan-3-yl)amino)pent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-methyl-4-(methyl(oxetan-3-yl)amino)pent-2-
enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-methyl-4-(methyl(oxetan-3-yl)amino)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(methyl(oxetan-3-yl)amino)pent-
2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(methyl(oxetan-3-yl)amino)pent-
2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
(carbonyl)-4-methyl-4-(methyl(oxetan-3-yl)amino)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-methyl-4-(methyl(oxetan-3-yl)amino)pent-2-
enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methyl-4-(methyl(oxetan-3-yl)amino)pent-2-
enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-methyl-4-(methyl(oxetan-3-yl)amino)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4-dimethyl-4-(methyl(oxetan-3-yl)amino)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-
enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-
enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-
enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-
enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-
enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-
enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-methyl-4-(4-methylpiperazin-1-yl)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4-dimethyl-4-(4-methylpiperazin-1-yl)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-(ethyl(oxetan-3-yl)amino)-4-methylpent-
2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-(ethyl(oxetan-3-yl)amino)-4-methylpent-2-
enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-(ethyl(oxetan-3-yl)amino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-(ethyl(oxetan-3-yl)amino)-4-methylpent-2-
enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-(ethyl(oxetan-3-yl)amino)-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(ethyl(oxetan-3-yl)amino)-4-methylpent-2-
enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(ethyl(oxetan-3-yl)amino)-4-methylpent-2-
enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-(ethyl(oxetan-3-yl)amino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-(ethyl(oxetan-3-yl)amino)-4-methylpent-2-
enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-(ethyl(oxetan-3-yl)amino)-4-methylpent-2-
enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(ethyl(oxetan-3-yl)amino)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(ethyl(oxetan-3-yl)amino)-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-
6-yl)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)pent-
2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)pent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)pent-
2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-
yl)pent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-
yl)pent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-
yl)pent-2-enenitrile;;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)pent-
2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-methyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4-dimethyl-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-methyl-4-(oxetan-3-ylamino)pent-2-
enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methyl-4-(oxetan-3-ylamino)pent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-methyl-4-(oxetan-3-ylamino)pent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-methyl-4-(oxetan-3-ylamino)pent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-methyl-4-(oxetan-3-ylamino)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(oxetan-3-ylamino)pent-2-
enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(oxetan-3-ylamino)pent-2-
enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-methyl-4-(oxetan-3-ylamino)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-methyl-4-(oxetan-3-ylamino)pent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methyl-4-(oxetan-3-ylamino)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-methyl-4-(oxetan-3-ylamino)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4-dimethyl-4-(oxetan-3-ylamino)pent-2-enamide;
2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-methyl-4-(piperazin-1-yl)pent-2-
enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methyl-4-(piperazin-1-yl)pent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-methyl-4-(piperazin-1-yl)pent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-methyl-4-(piperazin-1-yl)pent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-methyl-4-(piperazin-1-yl)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(piperazin-1-yl)pent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(piperazin-1-yl)pent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-methyl-4-(piperazin-1-yl)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-methyl-4-(piperazin-1-yl)pent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methyl-4-(piperazin-1-yl)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-methyl-4-(piperazin-1-yl)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4-dimethyl-4-(piperazin-1-yl)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-3-(3-methyloxetan-3-yl)acrylonitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-3-(3-methyloxetan-3-yl)acrylonitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-3-(3-methyloxetan-3-yl)acrylonitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-3-(3-methyloxetan-3-yl)acrylamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-3-(3-methyloxetan-3-yl)acrylamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-3-(3-methyloxetan-3-yl)acrylonitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-3-(3-methyloxetan-3-yl)acrylonitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-3-(3-methyloxetan-3-yl)acrylonitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-3-(3-methyloxetan-3-yl)acrylonitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-3-(3-methyloxetan-3-yl)acrylamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
3-(3-methyloxetan-3-yl)acrylamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N-methyl-3-(3-methyloxetan-3-yl)acrylamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-methyl-4-(piperidin-1-yl)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methyl-4-(piperidin-1-yl)pent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-methyl-4-(piperidin-1-yl)pent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-methyl-4-(piperidin-1-yl)pent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-methyl-4-(piperidin-1-yl)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(piperidin-1-yl)pent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(piperidin-1-yl)pent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-methyl-4-(piperidin-1-yl)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-methyl-4-(piperidin-1-yl)pent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methyl-4-(piperidin-1-yl)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-methyl-4-(piperidin-1-yl)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4-dimethyl-4-(piperidin-1-yl)pent-2-enamide;
(R,S), (R,R), (S,R)or (S,S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-
purin-9(8H)-yl)methyl)pyrrolidine-1-carbonyl)-3-(pyrrolldin-2-yl)acrylonitrile;
(R,S), (R,R), (S,R)or (S,S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-
purin-9(8H)-yl)piperidine-1-carbonyl)-3-(pyrrolidin-2-yl)acrylonitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-3-(pyrrolidin-2-yl)acrylonitrile;
(R,S), (R,R), (S,R)or (S,S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-
purin-9(8H)-yl)propan-2-yl)-2-cyano-3-(pyrrolidin-2-yl)acrylamide;
(RS), (R), or (S)-N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)cyclohexyl)-2-cyano-3-(pyrrolidin-2-yl)acrylamide;
(R,S), (R,R), (S,R)or (S,S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-
purin-9(8H)-yl)methyl)azetidine-1-carbonyl)-3-(pyrrolidin-2-yl)acrylonitrile;
(RS), (R), or (S)-2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-3-(pyrrolidin-2-yl)acrylonitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)azetidine-1-carbonyl)-3-(pyrrolidin-2-yl)acrylonitrile;
(R,S), (R,R), (S,R)or (S,S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-
purin-9(8H)-yl)pyrrolidine-1-carbonyl)-3-(pyrrolidin-2-yl)acrylonitrile;
(RS), (R), or (S)-N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)-2,2-dimethylpropyl)-2-cyano-3-(pyrrolidin-2-yl)acrylamide;
(RS), (R), or (S)-N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)ethyl)-2-cyano-3-(pyrrolidin-2-yl)acrylamide;
(RS), (R), or (S)-N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)ethyl)-2-cyano-N-methyl-3-(pyrrolidin-2-yl)acrylamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-(cyclopropylamino)-4-methylpent-2-
enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-(cyclopropylamino)-4-methylpent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-(cyclopropylamino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-(cyclopropylamino)-4-methylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-(cyclopropylamino)-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(cyclopropylamino)-4-methylpent-2-
enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(cyclopropylamino)-4-methylpent-2-
enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-(cyclopropylamino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-(cyclopropylamino)-4-methylpent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-(cyclopropylamino)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(cyclopropylamino)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(cyclopropylamino)-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-3-(1-aminocyclopropyl)acrylonitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-3-(1-aminocyclopropyl)acrylonitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-3-(1-aminocyclopropyl)acrylonitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-3-(1-aminocyclopropyl)-2-cyanoacrylamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-3-
(1-aminocyclopropyl)-2-cyanoacrylamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-3-(1-aminocyclopropyl)acrylonitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-3-(1-aminocyclopropyl)acrylonitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-3-(1-aminocyclopropyl)acrylonitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-3-(1-aminocyclopropyl)acrylonitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-3-(1-aminocyclopropyl)-2-cyanoacrylamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-3-(1-
aminocyclopropyl)-2-cyanoacrylamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-3-(1-
aminocyclopropyl)-2-cyano-N-methylacrylamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-(azetidin-1-yl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-(azetidin-1-yl)-4-methylpent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-(azetidin-1-yl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-4-(azetidin-1-yl)-2-cyano-4-methylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-4-
(azetidin-1-yl)-2-cyano-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(azetidin-1-yl)-4-methylpent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(azetidin-1-yl)-4-methylpent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-(azetidin-1-yl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-(azetidin-1-yl)-4-methylpent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-4-(azetidin-1-yl)-2-cyano-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-4-
(azetidin-1-yl)-2-cyano-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-4-
(azetidin-1-yl)-2-cyano-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-methyl-4-(pyrrolidin-1-yl)pent-2-
enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-methyl-4-(pyrrolidin-1-yl)pent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-methyl-4-(pyrrolidin-1-yl)pent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-methyl-4-(pyrrolidin-1-yl)pent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-methyl-4-(pyrrolidin-1-yl)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(pyrrolidin-1-yl)pent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-methyl-4-(pyrrolidin-1-yl)pent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-methyl-4-(pyrrolidin-1-yl)pent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-methyl-4-(pyrrolidin-1-yl)pent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-methyl-4-(pyrrolidin-1-yl)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-methyl-4-(pyrrolidin-1-yl)pent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
N,4-dimethyl-4-(pyrrolidin-1-yl)pent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-
enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-
enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-
enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-
enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-
enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-
enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(3-hydroxyazetidin-1-yl)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(3-hydroxyazetidin-1-yl)-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-
enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-
enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-
enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-
enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-
enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-
enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-
enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(4-hydroxypiperidin-1-yl)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(4-hydroxypiperidin-1-yl)-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-5-hydroxy-4,4-dimethylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-5-hydroxy-4,4-dimethylpent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-5-hydroxy-4,4-dimethylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-5-hydroxy-4,4-dimethylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-5-hydroxy-4,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-5-hydroxy-4,4-dimethylpent-2-enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-5-hydroxy-4-dimethylpent-2-enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-5-hydroxy-4,4-dimethylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-5-hydroxy-4,4-dimethylpent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-5-hydroxy-4,4-dimethylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
5-hydroxy-4,4-dimethylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
5-hydroxy-4,4-trimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-(isopropylamino)-4-methylpent-2-
enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-(isopropylamino)-4-methylpent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-(isopropylamino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-(isopropylamino)-4-methylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-(isopropylamino)-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(isopropylamino)-4-methylpent-2-
enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(isopropylamino)-4-methylpent-2-
enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-(isopropylamino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-(isopropylamino)-4-methylpent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-(isopropylamino)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(isopropylamino)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(isopropylamino)-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-(4-ethylpiperazin-1-yl)-4-methylpent-2-
enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-(4-ethylpiperazin-1-yl)-4-methylpent-2-enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-(4-ethylpiperazin-1-yl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-(4-ethylpiperazin-1-yl)-4-methylpent-2-enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-(4-ethylpiperazin-1-yl)-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(4-ethylpiperazin-1-yl)-4-methylpent-2-
enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-(4-ethylpiperazin-1-yl)-4-methylpent-2-
enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-(4-ethylpiperazin-1-yl)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-(4-ethylpiperazin-1-yl)-4-methylpent-2-enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-(4-ethylpiperazin-1-yl)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(4-ethylpiperazin-1-yl)-4-methylpent-2-enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-(4-ethylpiperazin-1-yl)-N,4-dimethylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)pyrrolidine-1-carbonyl)-4-((2-methoxyethyl)amino)-4-methylpent-
2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)piperidine-1-carbonyl)-4-((2-methoxyethyl)amino)-4-methylpent-2-
enenitrile;
2-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)piperidine-1-
carbonyl)-4-((2-methoxyethyl)amino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-N-(1-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)propan-2-yl)-2-cyano-4-((2-methoxyethyl)amino)-4-methylpent-2-
enamide;
N-(4-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)cyclohexyl)-2-
cyano-4-((2-methoxyethyl)amino)-4-methylpent-2-enamide;
(RS), (R), or (S)-2-(2-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-((2-methoxyethyl)amino)-4-methylpent-2-
enenitrile;
2-(3-((6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)methyl)azetidine-1-carbonyl)-4-((2-methoxyethyl)amino)-4-methylpent-2-
enenitrile;
2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)azetidine-1-
carbonyl)-4-((2-methoxyethyl)amino)-4-methylpent-2-enenitrile;
(RS), (R), or (S)-2-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-
yl)pyrrolidine-1-carbonyl)-4-((2-methoxyethyl)amino)-4-methylpent-2-
enenitrile;
N-(3-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)-2,2-
dimethylpropyl)-2-cyano-4-((2-methoxyethyl)amino)-4-methylpent-2-
enamide;
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-((2-methoxyethyl)amino)-4-methylpent-2-enamide; and
N-(2-(6-amino-8-oxo-7-(4-phenoxyphenyl)-7H-purin-9(8H)-yl)ethyl)-2-cyano-
4-((2-methoxyethyl)amino)-N,4-dimethylpent-2-enamide;
or a pharmaceutically acceptable salt thereof;
or an (E) or (Z) isomer or a mixture of (E) and (Z) isomer of any of the above compounds.
